Csaba Gajdos

Summary

Affiliation: Northwestern University
Country: USA

Publications

  1. ncbi request reprint Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer
    Csaba Gajdos
    Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA
    J Surg Oncol 80:4-11. 2002
  2. ncbi request reprint Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex
    Bin Chen
    Robert H Lurie Comprehensive Cancer Center, The Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    Int J Oncol 27:327-35. 2005
  3. ncbi request reprint Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy
    Clodia Osipo
    Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    J Steroid Biochem Mol Biol 93:249-56. 2005
  4. ncbi request reprint Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer
    Clodia Osipo
    Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    J Natl Cancer Inst 95:1597-608. 2003
  5. ncbi request reprint Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo
    Hong Liu
    Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    J Natl Cancer Inst 95:1586-97. 2003
  6. ncbi request reprint A mechanism of drug resistance to tamoxifen in breast cancer
    Jennifer MacGregor Schafer
    Robert H Lurie Comprehensive Cancer Center, The Feinberg School of Medicine, Northwestern University, Olson Pavilion 8258, 303 East Chicago Avenue, Chicago, IL 60611, USA
    J Steroid Biochem Mol Biol 83:75-83. 2002
  7. ncbi request reprint Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade
    Csaba Gajdos
    Robert H Lurie Comprehensive Cancer Center, Northwestern University Medical School, 303 E Chicago Avenue, Chicago, IL 60611, USA
    Clin Breast Cancer 2:272-81. 2002
  8. ncbi request reprint Effects of raloxifene after tamoxifen on breast and endometrial tumor growth in athymic mice
    Ruth M O'Regan
    Division of Hematology Oncology, Northwestern University, Chicago, IL 60611, USA
    J Natl Cancer Inst 94:274-83. 2002
  9. ncbi request reprint The prognostic significance of Gail model risk factors for women with breast cancer
    Paul Ian Tartter
    Department of Surgery, St Luke s Roosevelt Hospital Center, New York, NY, USA
    Am J Surg 184:11-5. 2002
  10. pmc Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics
    Csaba Gajdos
    Department of Surgery, The Mount Sinai Medical Center, New York, New York, USA
    Ann Surg 235:246-51. 2002

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer
    Csaba Gajdos
    Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA
    J Surg Oncol 80:4-11. 2002
    ..Therefore, clinical or pathological factors, which predict or assess response to treatment, may predict outcome after consideration for initial extent of disease...
  2. ncbi request reprint Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex
    Bin Chen
    Robert H Lurie Comprehensive Cancer Center, The Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    Int J Oncol 27:327-35. 2005
    ..We conclude that endogenous ERbeta may not play a dominant role in the modulation of the tamoxifen ERalpha complex, or in the development of tamoxifen-stimulated resistant tumor growth...
  3. ncbi request reprint Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy
    Clodia Osipo
    Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    J Steroid Biochem Mol Biol 93:249-56. 2005
    ..Based on the results, we suggest using an alternating treatment regimen, cycling antiestrogen with estrogen therapy to avoid drug-resistance...
  4. ncbi request reprint Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer
    Clodia Osipo
    Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    J Natl Cancer Inst 95:1597-608. 2003
    ..We investigated the molecular mechanism(s) of estradiol-induced tumor regression by using an in vivo model of tamoxifen-stimulated human breast cancer...
  5. ncbi request reprint Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo
    Hong Liu
    Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    J Natl Cancer Inst 95:1586-97. 2003
    ..We developed a raloxifene-resistant MCF-7 cell model (MCF-7/Ral) and investigated the nature of raloxifene-resistant breast cancer and its response to estradiol...
  6. ncbi request reprint A mechanism of drug resistance to tamoxifen in breast cancer
    Jennifer MacGregor Schafer
    Robert H Lurie Comprehensive Cancer Center, The Feinberg School of Medicine, Northwestern University, Olson Pavilion 8258, 303 East Chicago Avenue, Chicago, IL 60611, USA
    J Steroid Biochem Mol Biol 83:75-83. 2002
    ..Three phases of tumor progression are described that involve increases in HER-2/neu expression, de-regulation of estrogen receptor expression and increases in apoptosis which in concert determine the phenotype of drug resistance to Tam...
  7. ncbi request reprint Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade
    Csaba Gajdos
    Robert H Lurie Comprehensive Cancer Center, Northwestern University Medical School, 303 E Chicago Avenue, Chicago, IL 60611, USA
    Clin Breast Cancer 2:272-81. 2002
    ....
  8. ncbi request reprint Effects of raloxifene after tamoxifen on breast and endometrial tumor growth in athymic mice
    Ruth M O'Regan
    Division of Hematology Oncology, Northwestern University, Chicago, IL 60611, USA
    J Natl Cancer Inst 94:274-83. 2002
    ..We evaluated the effects on tumor growth of raloxifene, another SERM, after tamoxifen treatment in mouse models of breast and endometrial cancers...
  9. ncbi request reprint The prognostic significance of Gail model risk factors for women with breast cancer
    Paul Ian Tartter
    Department of Surgery, St Luke s Roosevelt Hospital Center, New York, NY, USA
    Am J Surg 184:11-5. 2002
    ..In order to assess the prognostic value of risk factors for breast cancer we divided patients with breast cancer into those at high risk and low risk using the Gail model...
  10. pmc Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics
    Csaba Gajdos
    Department of Surgery, The Mount Sinai Medical Center, New York, New York, USA
    Ann Surg 235:246-51. 2002
    ..To study the relationship of mammographic appearance of nonpalpable breast cancer to the pathologic characteristics...